L'anti-oncogène p19 Arf est impliqué dans le développement de l'obésité et de ses complications métabolique

Key Points

• Metabolic complications are associated with the anti-oncogene p19 arf's involvement in obesity development, demonstrating a critical link.
• The study shows significant implications of p19 arf in the metabolic pathways related to obesity, which may influence treatment strategies.
• Through a comprehensive analysis, the interplay between obesity and the anti-oncogene p19 arf was assessed, shedding light on potential therapeutic targets.
• Understanding p19 arf's role in obesity may enable new approaches to tackle metabolic disorders linked to obesity.